These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 7107352

  • 1. Misonidazole in patients receiving radical radiotherapy: pharmacokinetic effects of phenytoin, tumor response and neurotoxicity.
    Moore JL, Paterson IC, Dawes PJ, Henk JM.
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):361-4. PubMed ID: 7107352
    [Abstract] [Full Text] [Related]

  • 2. The role of microsomal enzyme inducers in the reduction of misonidazole neurotoxicity.
    Jones DH, Bleehen NM, Workman P, Smith NC.
    Br J Radiol; 1983 Nov; 56(671):865-70. PubMed ID: 6626878
    [Abstract] [Full Text] [Related]

  • 3. Pilot study of radiotherapy with misonidazole in head and neck cancer.
    Paterson IC, Dawes PJ, Henk JM, Moore JL.
    Clin Radiol; 1981 Mar; 32(2):225-9. PubMed ID: 7214840
    [Abstract] [Full Text] [Related]

  • 4. Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.
    Moore JL, Paterson IC, Newman H, Venables S.
    Br J Cancer; 1981 Oct; 44(4):592-6. PubMed ID: 7295516
    [No Abstract] [Full Text] [Related]

  • 5. Kinetic aspects of misonidazole and its major metabolite in radiotherapy.
    Meering PG, Gonzalez DG, Maes RA, van Peperzeel HA.
    Hum Toxicol; 1985 Jul; 4(4):425-34. PubMed ID: 4018823
    [Abstract] [Full Text] [Related]

  • 6. The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone.
    Wasserman TH, Phillips TL, Van Raalte G, Urtasun R, Partington J, Koziol D, Schwade JG, Gangji D, Strong JM.
    Br J Radiol; 1980 Feb; 53(626):172-3. PubMed ID: 6245744
    [No Abstract] [Full Text] [Related]

  • 7. A report on misonidazole in randomized trial in locally advanced head and neck cancer.
    Sealy R, Williams A, Cridland S, Stratford M, Minchinton A, Hallet C.
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(3-4):339-42. PubMed ID: 7050035
    [Abstract] [Full Text] [Related]

  • 8. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of head and neck cancer. MRC working party on misonidazole in head and neck cancer.
    Br J Radiol; 1984 Jul; 57(679):585-95. PubMed ID: 6329395
    [Abstract] [Full Text] [Related]

  • 9. Initial pharmacology and toxicology of intravenous desmethylmisonidazole.
    Coleman CN, Wasserman TH, Phillips TL, Strong JM, Urtasun RC, Schwade JG, Johnson RJ, Zagars G.
    Int J Radiat Oncol Biol Phys; 1982 Jul; 8(3-4):371-5. PubMed ID: 7107354
    [Abstract] [Full Text] [Related]

  • 10. The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. A pilot study of the Radiotherapy Group of the EORTC (European Organisation for Research on Treatment of Cancer).
    Van den Bogaert W, van der Schueren E, Horiot JC, Chaplain G, Arcangeli G, Gonzalez D, Svoboda V.
    Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1649-55. PubMed ID: 7153077
    [Abstract] [Full Text] [Related]

  • 11. Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs.
    Walker MD, Strike TA.
    Cancer Clin Trials; 1980 Oct; 3(2):105-9. PubMed ID: 6253094
    [Abstract] [Full Text] [Related]

  • 12. Effects of phenytoin, phenobarbital, and ascorbic acid on misonidazole elimination.
    Williams K, Begg E, Wade D, O'Shea K.
    Clin Pharmacol Ther; 1983 Mar; 33(3):314-21. PubMed ID: 6825387
    [Abstract] [Full Text] [Related]

  • 13. Clinical trials of misonidazole in the United States.
    Wasserman TH, Stetz J, Phillips TL.
    Cancer Clin Trials; 1981 Mar; 4(1):7-16. PubMed ID: 7214664
    [Abstract] [Full Text] [Related]

  • 14. Is misonidazole neurotoxicity altered by the use of phenytoin and/or dexamethasone in RTOG 79-18 and RTOG 79-16?
    Nelson DF, Gillespie BW, Diener MD, Davis DR, Wasserman T, Phillips TL, Stetz J.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1731-4. PubMed ID: 6384162
    [Abstract] [Full Text] [Related]

  • 15. Late results of multiple fractions per day (MFD) with misonidazole in advanced cancer of the head and neck. A pilot study of the EORTC radiotherapy group.
    Van den Bogaert W, van der Schueren E, Van Tongelen C, Horiot JC, Chaplain G, Arcangeli G, Gonzalez D, Svoboda V.
    Radiother Oncol; 1985 Feb; 3(2):139-44. PubMed ID: 3983422
    [Abstract] [Full Text] [Related]

  • 16. [Radiosensitization of hypoxic tumor cells with special reference to head and neck cancers].
    Kogelnik HD.
    Wien Klin Wochenschr; 1983 Aug 05; 95(15):515-8. PubMed ID: 6636784
    [Abstract] [Full Text] [Related]

  • 17. High dose misonidazole with dexamethasone rescue: a possible approach to circumvent neurotoxicity.
    Urtasun RC, Tanasichuk H, Fulton D, Agboola O, Turner AR, Koziol D, Raleigh J.
    Int J Radiat Oncol Biol Phys; 1982 Aug 05; 8(3-4):365-9. PubMed ID: 7107353
    [Abstract] [Full Text] [Related]

  • 18. The use of misonidazole in association with a three-fractions per day regimen in advanced head and neck epidermoid cancer. A pilot study.
    Awwad HK, Barsoum M, El Merzabani M, Omar S, El Badawy S, Ezzat S, El Baki HA, Zaki A.
    Am J Clin Oncol; 1983 Feb 05; 6(1):91-7. PubMed ID: 6301258
    [Abstract] [Full Text] [Related]

  • 19. The role of dexamethasone in the modification of misonidazole pharmacokinetics.
    Jones DH, Bleehen NM, Workman P, Walton MI.
    Br J Cancer; 1983 Oct 05; 48(4):553-7. PubMed ID: 6626454
    [Abstract] [Full Text] [Related]

  • 20. Dose-response curves for predicting misonidazole-induced peripheral neuropathy.
    Schwade JG, Makuch RW, Strong JM, Glatstein E.
    Cancer Treat Rep; 1982 Sep 05; 66(9):1743-50. PubMed ID: 6288238
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.